| Stage | PSIX | % of rev | CMI | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $153M | 100.00% | $9.5B | 100.00% | CMI ×62.00 |
| Gross profit | $41M | 27.12% | $2.5B | 26.07% | PSIX +1.1pp |
| Operating income | $24M | 15.68% | $1.3B | 13.52% | PSIX +2.2pp |
| Pre-tax income | $22M | 14.73% | $1.3B | 13.67% | PSIX +1.1pp |
| Net income | $17M | 11.05% | $968M | 10.24% | PSIX +0.8pp |
| Stage | PSIX | CMI | Gap · A − B |
|---|---|---|---|
| Revenue | $153M100.00% | $9.5B100.00% | CMI ×62.00 |
| Gross profit | 27.12%$41M | 26.07%$2.5B | PSIX +1.1pp |
| Operating income | 15.68%$24M | 13.52%$1.3B | PSIX +2.2pp |
| Pre-tax income | 14.73%$22M | 13.67%$1.3B | PSIX +1.1pp |
| Net income |
| 11.05%$17M |
| 10.24%$968M |
| PSIX +0.8pp |
No shared counterparties.